Clinical Trial

Advanced Therapeutics in Rheumatoid Arthritis (RA)

Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated November 29, 2024 (before its estimated March 2025 completion). Its status may not reflect the trial's current state.
Summary
This study will evaluate the retention rates of two advanced therapies, Tumour Necrosis Factor (TNF) and Janus kinase inhibitor (JAK) in the treatment of adults with Rheumatoid Arthritis (RA) over a two year period. It will also examine the ability to embed a clinical trial in a clinical situation using an electronic medical record (EMR).
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2019-06-03; most recent amendment 2024-11-26.
Status change: Not Yet Recruiting → Recruiting 2020-02-24
Trial Details
NCT Number NCT03976245
Lead Sponsor London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Collaborators: Academic Medical Organization of Southwestern Ontario
Conditions Rheumatoid Arthritis
Enrollment 144 participants
Start Date 2020-03-01
Primary Completion 2025-03 (estimated)
Study Completion 2025-03 (estimated)
Updated on ClinicalTrials.gov 2024-11-29